A51
Engineering the logic layer of biology
Paris, France · Founded 2024
About
A51 is a Paris-based deep tech biotech startup developing ADA, an RNA programming engine that uses programmable non-coding RNA molecules to modulate gene expression networks and correct pathological cellular states. The company targets complex diseases — including inflammation, auto-immunity, and neurodegeneration — by reprogramming entire cellular networks rather than single targets, using a high-throughput microfluidics platform coupled with AI to generate biological data at scale. Incubated at ESPCI Paris (PC'UP) and selected as a Deep Tech Pioneer by Hello Tomorrow, A51 won the French national i-Lab 2025 innovation award in its founding year.
Summary
A51 is an Artificial Intelligence company based in Paris, France, founded in 2024.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...